Bio-Techne (TECH) EV to EBITDA (2009 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) EV to EBITDA (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.30 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 144.91 |
| Mar 31, 2026 | 105.57 |
| Dec 31, 2025 | 165.15 |
| Sep 30, 2025 | 178.76 |
| Jun 30, 2025 | -327.37 |
| Mar 31, 2025 | 233.81 |
| Dec 31, 2024 | 236.13 |
| Sep 30, 2024 | 312.89 |
| Jun 30, 2024 | 244.05 |
| Mar 31, 2024 | 163.36 |
| Dec 31, 2023 | 315.48 |
| Sep 30, 2023 | 190.30 |
| Jun 30, 2023 | 133.98 |
| Mar 31, 2023 | 143.57 |
| Dec 31, 2022 | 188.88 |
| Sep 30, 2022 | 194.24 |
| Jun 30, 2022 | 165.40 |
| Mar 31, 2022 | 185.42 |
| Dec 31, 2021 | 321.78 |
| Sep 30, 2021 | 297.41 |